Chelated enolates of α-amino acids and peptides are suitable nucleophiles for the regioselective ring opening of epoxides. Depending on the substitution pattern, the reaction proceeds either in a S N 1-type (arylepoxides) or a S N 2-type (alkylepoxides) fashion, giving rise to γ-hydroxy α-amino acids.
Introduction
Epoxides are very versatile building blocks in organic synthesis, which can be opened up with a wide range of nucleophiles. 1 Elegant ring opening cascades found interesting applications in natural product synthesis, e.g. for macrocyclic polyethers. 2 To apply this protocol also to peptidic natural products, suitable amino acid and / or peptide nucleophiles are required. The epoxide opening with glycine enolates should give rise to γ-hydroxy α-amino acids, a structural motif widespread found in nature, e.g. in the glidobactins, 3 arborcandins 4 or the biphenomycins.
5
Suitable C-nucleophiles are either isocyanoacetates, 6 aminomalonates 7 or imino esters. 8 With chiral modified nucleophiles the stereochemical outcome of the reaction can be controlled. Berkowitz et al. reported the ring opening of ethylene oxide with various α-amino acid ester enolates. 10 Very recently, Crousse et al. reported the aminolysis of epoxides using α-amino acid and peptide esters.
11

Results and Discussion
Our group is also involved in amino acid and peptide synthesis, investigating reactions of chelated α-amino acid ester enolates. 12 These enolates not only show a higher stability compared to non-chelated enolates, but also a higher selectivity in a wide range of reactions such as aldol 13 and Michael additions, 14 as well as transition metal catalyzed allylic alkylations. 15 These reactions are not limited to amino acid enolates but can also be carried out with peptides, 16 while in several cases the stereochemical outcome of the reaction can be controlled by the stereogenic centers of the peptide chain. 17 To enlarge the synthetic potential of these chelated enolates we were interested to see if these enolates can also be used for regioselective epoxide openings. In general, a S N 2-type mechanism is discussed 1 resulting in an attack at the sterically least hindered position. This is reasonable for alkyl-substituted epoxides. Li 18 and Ramachandran 19 et al. investigated the opening of arylepoxides with allenoates and observed also a selective S N 2-attack at the terminal epoxide position, even in the presence of Lewis acids. This is also true for α-metalated carboxylic acids, 20 while with malonates either S N 1-type products are obtained or mixtures of both isomers.
21
Therefore, we investigated the reaction of both, alkyl-and aryl-substituted epoxides 1 ( Table  1) . As nucleophile we used the enolate of TFA-protected t-butyl glycinate, which gave excellent results e.g. in Michael additions or allylic alkylations. ZnCl 2 was used for chelation of the enolate and BF 3 · OEt 2 for the activation of the epoxide. The epoxide was used in slight excess (1.5 equiv.) to allow a complete conversion. In principle, two different products (2 and 3) can be formed. 2 is the preferred product of a S N 2-type ring opening, while 3 should be found under S N 1-conditions. With aliphatic epoxides the S N 2-product 2 was formed exclusively in high yield as a diastereomeric mixture (entries 1-5). The same is true for glycidyl ethers (entries [6] [7] [8] . In contrast, with aryl-substituted epoxides only the formation of the S N 1-product 3 was observed, giving rise to β-substituted phenylalanines (entries 9-11). Obviously, under the mild reaction conditions the nucleophilic attack on the in situ formed benzylic carbenium ion is significantly faster than the S N 2-attack.
To prove if this concept is also suitable for the modification of peptides, we subjected a phenylalanine dipeptide to analogous reaction conditions. Only the amount of base had to be increased to 3.5 equiv. LHMDS (lithium hexamethyldisilazide). To make the NMR spectra more clear by reducing the number of stereoisomers, the ring opening products were directly oxidized to the corresponding ketones 4 ( Table 2 ). The yields obtained were slightly lower compared to the amino ester enolates but with 64-72% (over both steps) still in a preparative useful range. 
Conclusions
In conclusion we could show that chelated enolates of α-amino acids and peptides are suitable nucleophiles for the regioselective ring opening of epoxides. Depending on the substitution pattern, the reaction proceeds either in a S N 1-type (arylepoxides) or a S N 2-type (alkylepoxides) fashion. Attempts to increase the stereoselectivity of these processes as well as synthetic applications are currently under investigation.
Experimental Section
General. All reactions were carried out in oven-dried glassware (100°C) General procedure for epoxide opening with amino acid enolates In a Schlenk tube hexamethyldisilazane (497 mg, 3.08 mmol) was dissolved in dry THF (5 mL) under Ar. After the solution was cooled to -78 °C, a 1.6 M solution of n-BuLi (1.72 mL, 2.75 mmol) was added slowly. The solution was stirred for 10 min before the cooling bath was removed and the solution was stirred for a further 10 min. In a second Schlenk flask ZnCl 2 (180 mg, 1.32 mmol) was dried with a heat gun under vacuum and dissolved in THF (5 mL) under Ar. Tfa-Gly-OtBu (250 mg, 1.1 mmol) was added and the solution was cooled to -78 °C before the LHMDS solution was added slowly via syringe. The resulting solution was stirred for 30 min at -78 °C. Then the corresponding epoxide (1.65 mmol) was added followed by BF 3. OEt 2 (78.1 mg, 0.55 mmol) directly to the enolate at -78 °C. The reaction mixture was allowed to warm to r.t. over night before it was hydrolyzed with 1M HCl and extracted thrice with ethyl acetate. The combined organic layers were dried (Na 2 SO 4 ), the solvent was evaporated in vacuo, and the crude product was purified by flash chromatography (silica gel, hexanes/EtOAc). 
tert-Butyl
13
C NMR (100 MHz, CDCl 3 ): δ = 169. 2, 155.8, 130.7, 83.3, 71.6, 67.4, 51.6, 33.8, 27.8 
C NMR (100 MHz, CDCl 3 ): δ = 168.7, 157.4 (J = 37.4 Hz), 135.9, 133.8, 129.9, 129.7, 127.5, 126.2, 115.6 (J = 285.8 Hz), 83.7, 63.4, 55.5, 48.9, 27.6 4, 129.6, 129.0, 84.4, 62.0, 53.4, 49.7, 28.0 
General procedure for epoxide opening with dipeptide enolates
In a oven-dried Schlenk tube hexamethyldisilazane (411 mg, 2.54 mmol) was dissolved in dry THF (5.0 mL) under Ar. After the solution was cooled to -78 °C, a 1.6 M solution of n-BuLi (1.5 mL, 2.34 mmol) was added slowly. The solution was stirred for 10 min before the cooling bath was removed and the solution was stirred for a further 10 min. In a second Schlenk flask ZnCl 2 (109 mg, 0.80 mmol) was dried with a heat gun under vacuum and dissolved in THF (2.0 mL) under Ar. The corresponding dipeptide (250 mg, 0.67 mmol) was added and the solution was cooled to -78 °C before the LHMDS solution was added slowly via syringe. The resulting solution was stirred for 60 min at -78 °C. Then the corresponding epoxide (1.0 mmol) was added directly to the enolate at -78 °C, followed by BF 3 · OEt 2 (47.4 mg, 0.34 mmol). The reaction mixture was allowed to warm to r.t. over night before it was hydrolyzed with 1M HCl and extracted three times with ethyl acetate. The combined organic layers were dried (Na 2 SO 4 ), the solvent was evaporated in vacuo, and the crude product was purified by flash chromatography (silica gel, hexanes/EtOAc).
Oxidation of substituted peptides
The combined organic layers of the epoxide opening reaction were dried (Na 2 SO 4 ) and the solvent was evaporated in vacuo. The crude product was re-dissolved in 10 ml dry dichloromethane and Dess-Martin periodinane (1.0 mmol) was added in one portion at 0 o C.
After the oxidation was complete (tlc), the reaction was quenched by a saturated aqueous solution of NaHCO 3 containing Na 2 S 2 O 3 and the product was extracted three times with ethyl acetate. The combined organic layers were dried (Na 2 SO 4 ), the solvent was removed in vacuo, and the crude product was purified by flash chromatography (silica gel, hexanes/EtOAc).
tert-Butyl 4-oxo-2-((S)-3-phenyl-2-(2,2,2-trifluoroacetamido)propanamido)pentanoate (4a).
Major diastereomer ( 
13
C NMR (100 MHz, CDCl 3 ): δ = 206.3, 168.9, 168.6, 156.9 (J = 37.5 Hz), 134. 8, 129.3, 128.7, 127.4, 115.6 (J = 285.6 Hz), 82.8, 54.2, 48.9, 44.7, 38.3, 29.8, 27.8 2, 168.7, 168.4, 134.8, 129.3, 128.7, 127.4, 82.8, 54.2, 48.9, 44.5, 38.3, 29.8, 27.7. HRMS (CI) 5 H), 7.14 (bs, 1 H), 6.82 (d, J = 7.5 Hz, 1 H), 1 H), 4.60 (td, J = 7.8, 4.3 Hz, 1 H), 4 H), 2 H), 1.44 (s, 9 H), 1.05 (t, J = 7.34 Hz, 3 H).
C NMR (100 MHz, CDCl 3 ): δ = 200. 7, 169.1, 168.6, 156.9 (J = 37.5 Hz), 134.9, 129.2, 128.7, 127.4, 115.6 (J = 285.6 Hz), 83.2, 54.4, 48.9, 41.3, 35.6, 38.2, 27.6, 7.9 . Minor diastereomer (33%, selected signals): 7, 169.1, 168.6, 134.9, 129.2, 128.7, 127.4, 83.2, 54.4, 47.6, 41.3, 38.2, 27.7, 8.0 6 H), 6.82 (d, J = 7.5 Hz, 1 H), 4.72 (m, 1 H), 4.60 (td, J = 7.8, 4.3 Hz, 1 H), 4.07 (d, J = 15.5 Hz, 1 H), 4.02 (d, J = 15.4 Hz, 1 H), 4 H), 1.44 (s, 9 H). 13 C NMR (100 MHz, CDCl 3 ): 200.7, 169.1, 168.6, 156.9 (J = 37.5 Hz), 134.9, 129.2, 128.7, 127.4, 115.6 (J = 285.6 Hz), 83.2, 54.4, 48.9, 47.6, 41.3, 38.2, 27.7 200.7, 169.1, 168.6, 129.2, 128.7, 127.4, 115, 83.2, 54.4, 48.9, 47.6, 41.3, 38.2, 27.7 7, 168.8, 168.7, 157.4, 156.5 (J = 37.3 Hz), 135.3, 129.7, 129.2, 128.7, 127.2, 121.9, 114.4, 115.6 (J = 285.9 Hz), 82.9, 72.3, 54.6, 48.1, 41.0, 38.5, 27.7 169.0, 168.9, 134.9, 129.6, 129.2, 128.6, 127.3, 121.8, 115.5 (J = 285.5 Hz), 82.9, 72.4, 54.3, 48.6, 41.0, 38.2, 27.7 168.8, 168.4, 156.9 (J = 37.5 Hz), 154.7, 151.6, 135.2, 129.2, 128.8, 127.4, 115.6 (J = 285.6 Hz), 115.5, 114.9, 83.0, 73.2, 55.7, 54.7, 48.2, 40.9, 38.6, 27.7 2, 168.8, 168.6, 156.9 (J = 37.5 Hz), 154.6, 129.3, 128.8, 127.5, 115.6 (J = 285.6 Hz), 115.5, 115.0, 114.8, 83.1, 73.3, 55.6, 54.3, 48.6, 41.0, 38.2, 27.8. HRMS (CI) (dd, J = 13.9, 6.7 Hz, 1 H), 3.07-3.14 (m, 2 H), 1.44 (s, 9 H).
C NMR (100 MHz, CDCl 3 ): δ = 205. 9, 168.8, 168.4, 156.9 (J = 37.5 Hz), 154.7, 151.6, 135.2, 129.3, 128.8, 127.3, 115.6 (J = 285.6 Hz), 115.4, 83.0, 73.2, 55.6, 54.7, 48.1, 40.9, 38.6, 27.7 . Minor diastereomer (36%, selected signals):
1 H NMR (400 MHz, CDCl 3 ): 7. 16-7.31 (m, 6 H), 6.82-6.87 (m, 4 H), 6.40 (d, 168.8, 168.6, 154.6, 129.3, 128.8, 127.5, 115.5, 115.0, 114.8, 83.1, 73.3, 55.6, 54.3, 48.6, 41.0, 38.2, 27.8 205.9, 168.8, 168.4, 156.9 (J = 37.5 Hz), 154.7, 151.6, 135.2, 129.3, 128.8, 127.3, 115.6 (J = 285.6 Hz), 115.4, 83.0, 73.2, 55.6, 54.7, 48.1, 40.9, 38.6, 27.7 8, 168.6, 154.6, 129.3, 128.8, 127.5, 115.5, 115.0, 114.8, 83.1, 73.3, 55.6, 54.3, 48.6, 41.0, 38.2, 27.8 
